We hypothesized that chronic tissue stress due to interaction of alloreactive donor cells with host epithelium after allogeneic hematopoietic cell transplantation (allo-HCT) may cause genomic alterations. We therefore analyzed 176 buccal samples obtained from 71 unselected allotransplanted patients for microsatellite instability (MSI). MSI was observed in 52% of allotransplanted patients but never in 31 healthy or autotransplanted controls. The patient age, the donor age, a female-tomale transplantation and a low number of CD34 þ cells in the graft were significantly correlated with genomic instability. There was a trend for increasing risk of MSI for patients who experienced severe graft-vs-host disease. Secondary malignancy was diagnosed in five (14%) of the MSI þ and only in one (3%) MSI À patient. In an in vitro model of mutation analysis we found significant induction of frameshift mutations and DNA strand breaks in HaCaT keratinocytes co-cultured with mixed lymphocyte cultures (MLCs) but not after their exposure to interferon-c, tumor necrosis factor-a, transforming growth factor-b (TGF-b), MLC supernatant, peripheral blood mononuclear cells (PBMCs) or phytohemagglutinin-stimulated PBMC. A reactive oxygen species-mediated mechanism is implicated. The in vivo and in vitro data of our study show that alloreactions after allo-HCT may induce genomic alterations in epithelium. Progress in understanding DNA damage and repair after allo-HCT can potentially provide molecular biomarkers and therapeutic targets.
Introduction
Allogeneic hematopoietic cell transplantation (allo-HCT) is an established curative therapy for many hematological malignancies. 1 Even in human leukocyte antigen-matched sibling transplantation immunocompetent donor cells may attack the antigenically foreign tissues of the transplant recipient, ultimately resulting in subclinical tissue stress or clinical graft-vs-host disease (GvHD). 2, 3 Transplant survivors, especially those who have chronic GvHD, are at risk for the development of secondary epithelial cancers. 4, 5 The pathogenesis of solid tumors after transplant is unknown.
Chronic tissue stress may induce DNA damage and genomic alterations. 6, 7 Genomic instability (GI), a hallmark of human cancers, has been recently detected in nonmalignant chronically inflamed tissues from patients with ulcerative colitis and rheumatoid arthritis. [8] [9] [10] The biological significance of GI in chronic inflammation settings is yet unknown. Although in ulcerative colitis GI has been associated with increased cancer risk, there is no such correlation in rheumatoid arthritis. 10, 11 Microsatellites are repetitive sequences widely dispersed throughout the genome that are inherited stably and therefore serve as valuable markers in linkage mapping and identity testing. 12, 13 The detection of microsatellite instability (MSI) is an established indicator of general GI. 12, 14, 15 We recently found frequent genomic alterations measured by MSI in nonneoplastic epithelial tissues of patients who underwent allo-HCT but not after autologous HCT. 16 In this study we not only confirmed our previous observations in a larger and independent patient cohort, but also identified clinical factors that influence the occurrence of GI and analyzed its clinical significance. Furthermore, in an in vitro system we found that the alloreactive microenvironment may be substantially involved in the mutation process and provide a mechanistic insight into this observation.
Materials and methods

Subjects and sample collection
Patients who underwent allo-HCT and followed up on an outpatient clinic basis participated in the institutional review board-approved study. Patient selection was based on the absence of clinical signs of mucositis at the time of buccal sampling. Buccal smear sampling was performed as previously described. 16 Buccal smears and 4 ml blood were also obtained from 16 healthy individuals and 15 patients who underwent autologous HCT and served as controls, after informed consent.
Analysis of microsatellite instability
DNA was extracted by QIAamp DNA Micro kit (Qiagen, Hilden, Germany). Microsatellite analysis was performed by singleplex PCR for THO-1, SEE33, D14S120 and D1S80 markers and analysis of the fragment sizes of the PCR products was performed by capillary electrophoresis (ABI Prism 310 Genetic Analyzer and GeneScan software; Applied Biosystems, Weiterstadt, Germany), as described. 16 Instability of a microsatellite marker in the allografted recipients and in control subjects was determined and quantified as previously described in detail. 16 
Mixed lymphocyte culture
Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll density-gradient separation from heparinized blood of healthy volunteers, after informed consent. One-way nonmatched mixed lymphocyte cultures (MLCs) were set up for 7 days according to standard protocols. Briefly, 5 Â 10 6 (responder) PBMCs from one donor were incubated with same amount of irradiated (30 Gy) (stimulator) PBMCs from a second donor in RPMI 1640 (Gibco) supplemented with 10% fetal bovine serum and 100 U/ml penicillin-streptomycin.
In vitro mutation analysis system
The human nontumorigenic keratinocyte cell line HaCaT (kindly provided by Prof Boukamp, Heidelberg) 17 was stably transfected with the pMV7pIHyg13 and pMV7pIHyg12 plasmids (kindly provided by Dr Zienolddiny, Norway) 18 using the retroviral packaging Phoenix ampho cells (Nolan, Stanford University), as published elsewhere. 19 Chromosomal integration of vectors was confirmed by PCR. 20 Briefly, the pMV7pIHyg13 plasmid vector carries a G418 neomycin resistance (neo r ) selectable marker and a hygromycin resistance (hyg r ) gene that is rendered out of frame for protein translation because of a microsatellite repeat (CA) 13 inserted after its ATG starting codon. Pools of stably transfected (neo r ) HaCaT/p13 cells were exposed to H 2 O 2 , interferon-g (IFN-g) (Strathmann Biotec, Hamburg, Germany), tumor necrosis factor (TNF-a), transforming growth factor-b (TGF-b) (Cellgenix, Freiburg, Germany), whole MLC or its cell-free supernatant (1:10 diluted), MLCs separated by a semipermeable membrane (0.4 mm pores) in a transwell system (Corning Inc., Corning, NY, USA), phytohemagglutinin (PHA; Sigma, St Louis, MO, USA; 10 mg/ml for 48 h)-stimulated PBMCs (ratio 1:1) and freshly isolated PBMCs (ratio 2:1). In some cases 5 mM N-acetyl cysteine (NAC; Sigma) a well-known antioxidant and free radical scavenger was added. After treatment, cells were left to recover in standard medium (Dulbecco's modified Eagle's medium/10% fetal bovine serum) for 48 h and then hyg r colonies were selected after hygromycin phosphotransferase B treatment (200 mg/ml) for 2-3 weeks. Hyg r colonies were fixed, stained with sulforhodamine B (Sigma) and counted. Mutant fraction for each experiment was calculated as the number of hyg r colonies corrected for relative to control cell survival as assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 21 Treatment conditions were adjusted so that at least 70% of survival was ensured. Induction of GI was expressed by comparing each mutant fraction with the number of hyg r colonies in experiment's internal control. The artificial microsatellite length alteration in hyg r colonies was confirmed by sequencing of the (CA) n repeat. 20 Cells transfected with the pMV7pIHyg12 vector carrying the (CA) 12 repeat (HaCaT/p12) were hyg r and served as positive controls.
DNA strand-break analysis, western blot of DNA repair proteins, intracellular reactive oxygen species and 8-oxo-deoxyguanosine levels DNA double-strand breaks were assessed using TBE Comet assay (Trevigen, Gaithersburg, MD, USA) and comet tails were quantified after silver staining by CometScore software (TriTek CometScore freeware v1. and analyzed by flow cytometry, as described. 23 The presence of oxidized guanine residues was detected by indirect fluorescent staining and flow cytometry using an anti-8-oxo-dG antibody (Trevigen) followed by a rabbit anti-mouse fluoresceinisothiocyanate-labeled secondary antibody (Jackson ImmunoResearch, West Grove, PA, USA).
Statistics
The occurrence of MSI was analyzed in relation to clinical factors using Student's t-test, Mann-Whitney test, w 2 -test or Fisher's exact test, depending on the nature of the data. Relative risk (RR) for MSI was expressed as odds ratio. The in vitro results were analyzed by Wilcoxon signed-rank test, unpaired Student's t-test or Mann-Whitney test. The Kaplan-Meier method was used to generate secondary malignancy distribution graphs and comparisons were carried out using the log-rank test. Po0.05 was considered statistically significant.
Results
Genomic instability in vivo
No MSI was detected in buccal samples obtained from 31 control subjects including 16 healthy individuals (median age 27 years, 23-49 years) and 15 patients who underwent autologous HCT after high-dose chemotherapy (median age 61 years, 32-70 years) Altogether, 47 samples taken 30-2792 days (median 250 days) after autologous HCT were analyzed for MSI and the median number of samples analyzed per patient was 2 (1-4) (Supplementary Table 1) .
We examined 195 buccal samples obtained from 71 allotransplanted patients (median samples analyzed/patient 2, 1-6) with median age at transplant 53 years (22-74 years). Nineteen of these samples were taken from 19 patients just before conditioning for allo-HCT and all were negative for MSI. In total, MSI was detected in 57 (32%) of 176 samples collected 30-3722 days (median 322 days) after allo-HCT ( Figure 1 ). There was no statistically significant correlation between MSI positivity and actual C-reactive protein level, ferritin level or presence and stage of active GvHD at the time point of buccal sampling (data not shown).
A total of 52 (73%) patients gave buccal samples more than once after allo-HCT with a median time interval between first and last sampling of 130 days (30-340). We did not observe any MSI in 34 of 71 (48%) patients of the study (MSI À group). MSI À patients had a median of 2 buccal samples analyzed (1-6). MSI was observed in 37 (52%) of 71 allotransplanted patients in at least one sample (MSI þ group; Figure 2 ). MSI þ patients had a median of 3 buccal samples analyzed (1-6) and the median number of MSI þ samples in MSI þ patients was 2 (1-3). To identify clinical factors that might influence the occurrence of MSI in an allotransplanted patient, we compared clinical features of MSI À and MSI þ patients (Table 1) . MSI þ patients were significantly older (median 60 years, 29-71 years) than MSI À patients (median 48 years, 22-74 years) (P ¼ 0.005). The positive effect of patient age in MSI occurrence remained when the patients were categorized according to the 55th year of age at transplant (P ¼ 0.012). In addition, MSI þ patients received a graft from significantly older donors (P ¼ 0.045) and received significantly lower number of CD34 þ cells per kg body weight than MSI À patients (P ¼ 0.043). Interestingly, the occurrence of MSI was significantly favored from a female donor sex (P ¼ 0.024) and especially from a female to male sex mismatched transplantation (P ¼ 0.009). There was no statistically significant relationship between the occurrence of MSI and the other clinical factors indicated in Table 1 . We estimated the RR for MSI in association with the absence (RR ¼ 1) or occurrence of GvHD by comparing histories of GvHD in MSI þ and MSI À patients. Though there was no statistically significant correlation between MSI and GvHD history, we observed a trend for increasing risk of MSI as the severity of GvHD increased ( Table 2 ). The risk for MSI was higher among those patients who experienced serious (4grade II) acute GvHD or extensive chronic GvHD than it was in patients with no acute and no chronic GvHD (RR ¼ 1.847, P ¼ 0.208).
Genomic instability and secondary neoplasia
Overall, in six patients included in the study a diagnosis of secondary epithelial malignancy was carried out. All cases except one were skin cancers but none in the oral cavity. Five (14%) of the patients with secondary malignancy were included in the MSI þ group and only one (3%) in the MSI À group. As the risk for secondary malignancy after allo-HCT increases over time, 5 we examined development of secondary malignancy in the two groups as a time-dependent variable ( Figure 2b ). The probability of secondary tumor development was significant higher in the MSI þ as compared to the MSI À patients (P ¼ 0.024, hazard ratio ¼ 6.68, 95% confidence interval 1.27-35.0).
Genomic instability in vitro
We examined whether factors involved in alloreactions can induce GI in cultured human keratinocytes. First, we established an in vitro model of mutation analysis in which genomic instable HaCaT/p13 keratinocytes become detectable as hygromycin-resistant clones (Figure 3a) . Treatment of HaCaT/ p13 cells with H 2 O 2 resulted in a dose-dependent induction of GI (1.9-to 5.7-fold) (Figure 3b ). We performed one-way nonmatched MLCs and cocultured them with HaCaT/p13 cells. MLCs caused significant GI induction above experiment's internal control in 9 of 11 cases (mean 2.9-fold, 1-5.6) whereas the cell-free corresponding MLC supernatants (MLC-SN) did not show this effect (mean 1-fold, 0.8-1.4) (Figure 3c ). Conversely, no significant MSI was induced after short-term exposure of the HaCaT/p13 cells to cytokines abundant in the alloreactions such IFN-g, TNF-a and TGF-b (mean 1-fold, 0.5-1.6), coculture with MLC in a semipermeable transwell system (mean 1.3-fold, 1-1.9) or with freshly isolated PBMCs from healthy donors (mean 1.1, 1-1.2) (Figure 3d ). Interestingly, unspecific stimulation of PBMCs by PHA (PHA-PBMC) did not result in any GI in HaCaT/ p13 cells underscoring the importance of allostimulation (mean onefold, 0.8-1.2) (Figure 3d ). PBMC obtained from five allotransplanted patients (two MSI þ ) were also tested in our system but no GI induction was detected. GI was also evaluated in terms of DNA strand-break formation using the TBE comet assay (Figure 4a 
Mechanisms of GI induction
We further examined the possible mutagenic mechanism of alloreactions. The MLC-induced GI in HaCaT/p13 was inhibited when the antioxidant NAC was added into the medium implicating a mechanistic role of ROS in the mutation process (Figure 3d) . Indeed, MLC treatment caused a significant increase of intracellular ROS in HaCaT/p13 cells above background levels as compared to treatment with MLC-SN (P ¼ 0.012), TNF-a (P ¼ 0.018), IFN-g (P ¼ 0.005), fresh PBMC (P ¼ 0.007) or PHA-PBMC (P ¼ 0.007) (Figures 4c and d) . Furthermore, measurement of 8-oxo-deoxyguanosine (8-oxo-dG) residue formation in HaCaT/p13 cells exposed to MLC revealed significant oxidative damage compared with untreated cells (P ¼ 0.017), cells exposed to MLC-SN (P ¼ 0.024) or to PHA-PBMC (P ¼ 0.004). In contrast, MLC-SN and PHA-PBMC treatment was not sufficient to produce significant oxidatively damaged DNA (Figure 4e ). No changes of the mismatch repair proteins (MSH2, MSH3, MSH6, PMS1, PMS2, MLH1) and p53 protein levels were detectable by western blotting on treatment with MLC or MLC-SN (Supplementary Figure 1) .
Discussion
We have previously shown frequent genomic alterations measured as MSI in nonmalignant tissues after allo-HCT. 16 The results reported in this study confirmed and strengthened our previous findings in a larger and independent patient cohort of 71 allotransplanted patients. MSI of the nonmalignant oral mucosa was observed in 52% of allotransplanted patients but never in 31 healthy or autotransplanted controls or in patients before receiving allo-HCT. It must be noticed that autotransplanted patients were age matched and received similar Table 1 ). Moreover, in this study we identified four clinical factors to significantly correlate with the detection of MSI: the age of the patient, the age of the donor, a female sex of the donor and especially a female-to-male transplantation, and a low number of CD34 þ cells in the graft. The link between age and accumulation of mutations is well documented. 24 The correlation between older patient age and MSI underscores the finding that there was no effect of the intensity of conditioning in the occurrence of MSI as older patients (455 years) received reduced intensity instead of standard myeloablative conditioning. Irradiation 25 as well as iron overload 26 has been suggested to cause DNA damage, but there was no such correlation in our patient cohort.
Although the fluctuation of sampling positivity within an individual patient may suggest that MSI is a transient event influenced by distinct clinical features at the time of sampling, we could not find such clinical correlations. This variation is perhaps not unexpected. A reproduced MSI pattern over time would indicate a stable propagation of the mutation in a basal buccal cell able to sustain the specific alteration in the progeny. 27 However, microsatellite replication errors occur randomly, they will presumably confer no growth advantage and there is rapid renewal of buccal epithelium (4-5 days), thus ensuring variability about the percent instability and the presence of different unstable microsatellite markers in different regions of the buccal epithelium. Indeed, regional variability and variability in the type of mutated microsatellite have been shown to be responsible for sampling error and misclassification of tumors as MSI þ or MSI À . 28, 29 Finally, we believe that one Abbreviations: CI, confidence interval; GvHD, graft-vs-host disease; RR, relative risk. At time of buccal sampling patients had no mucositis or oral GvHD.
Alloreactions after HCT induce genomic alterations M Themeli et al factor that probably contributes to the fluctuation seen in our patients is false negativity resulting from excess normal tissue, 30 as is suggested by the observation that the high extent of MSI in a sample was predictive for the positivity of the subsequent sample. Evidently, distinguishing patients that remain MSI þ over time from those who became truly MSI negative would require for statistical considerations multiple sampling and typing a high number of microsatellite markers every time.
There are several strong indicators that a chronic 'alloantigenic' effect is operative in MSI generation in the allografted patients. First, MSI was found only in allotransplanted patients but not in age-matched autotransplanted patients with similar diseases receiving high-dose chemotherapies. Second, MSI in 19 patients was evident only after but not before the allo-HCT. Third, MSI was detected not only at short intervals after conditioning when acute toxicity takes place but also many years after transplantation. Fourth, MSI was observed significantly more frequently in male recipients transplanted from female donors, a sex combination that enhances immune responses through Y-chromosome-encoded gene products and has been consistently associated with the development of chronic GvHD. 31, 32 In addition, MSI was found significantly more frequently in older patients and in patients transplanted from older donors, factors that have also been correlated with GvHD in several studies. 33, 34 Patients with clinical signs of mucositis or oral GvHD were excluded from buccal sampling in our study indicating that the alloantigenic effect that produces MSI occurred irrespectively to the presence of local GvHD-related inflammation. Though there was no statistically significant correlation between MSI and GvHD history, we observed a trend for increasing risk of MSI as the severity of GvHD increased (Table 2) . It must be noticed that the nature of our study is observational and therefore has major limitations in determining associations between GvHD and MSI occurrence. Other studies designed to specifically untangle the causality of GvHD in MSI in which patient selection is based on the history of overt or subclinical (bioptically proven) GvHD and sample analysis is performed prospectively in fixed time points after the occurrence of GvHD are needed to make more clear conclusions.
To further investigate the hypothesis that factors implicated in alloreactions may have a role in the occurrence of MSI, we established an in vitro coculture system of mutation analysis with primary allostimulated MLCs as effector cells and the human nontumorigenic keratinocyte HaCaT cells as targets. Although our in vitro model cannot exactly mimic the GvHD microenviroment, the results of our study show that exogenous factors such as in vitro allostimulated MLCs can induce GI as significant induction of frameshift mutations and DNA strand breaks were detected when HaCaT cells were cocultured with MLCs from different volunteers. Type of PBMC stimulation might be of importance as co-cultivation of HaCaT cells with unspecifically PHA-stimulated PBMCs did not result in any GI induction. Unlike in vitro allostimulated MLCs, freshly isolated PBMCs obtained from allotransplanted patients could not induce GI in our in vitro system. There are several possible explanations for that. Although the same allospecific T-cell clones have been identified both in GvHD lesions and peripheral blood, 35 the frequency of alloreactive clonotypes is much lower in the circulation as compared to target tissues. 36, 37 In addition, the degree of human leukocyte antigen mismatches in random MLCs results in higher level of T cell activation as compared to the human leukocyte antigen matched setting of the donor/recipient pair. 38, 39 Instead of using post-transplant heterogeneic PBMCs and HaCaT cells as targets, testing of GvHD-related immunodominant T-cell clones isolated from GvHD lesions in a human skin explant model, 40 will probably be more appropriate to predict which patients will develop MSI. Nevertheless, our in vitro study results are proof of principle that alloreactive cells may induce genomic alterations in cocultured epithelial cells. Several hypotheses could be made on which of the factors in MLC could be responsible for causing GI and by which mechanism. Cytokines abundant in GvHD and soluble factors released from activated MLCs failed to induce any GI. Nevertheless, it must be mentioned that in our system the exposure of the keratinocytes in cytokines was short in contrast to chronic exposure to inflammatory cytokines, which has been shown to induce GI in colon cell lines. 41 One can hypothesize that a close contact of the activated cells in MLCs with the epithelial cells is mainly involved in the mutation process. Preliminary data of our group indicate that in addition to activated cells, also apoptotic lymphocytes in one-way MLCs may contribute to the induction of GI.
The mutagenic mechanism of MLCs needs further clarification. Although we found no significant alterations of mismatch repair and p53 levels, MLC treatment resulted in generation of intracellular ROS, 8-oxo-dG DNA lesions and DNA strand breaks in HaCaT cells. The possible causative role of oxidative stress in GI induction is pointed out by the inhibition of the phenomenon by antioxidants. ROS can cause MSI by multiple mechanisms. 20, 42, 43 ROS induce chemical modifications and conformational changes (for example, strand breaks) in DNA, which within the context of a microsatellite may result in strand misalignment, impairment of the polymerase replication accuracy and subsequent generation of insertion or deletion loops. 6, 42, 43 Furthermore, intracellular-produced free radicals cause direct oxidative DNA damage that may overwhelm the capacity of repair pathways. 42, 44 Finally, ROS may induce DNA alterations indirectly by oxidation and inactivation of repair proteins. 6, 45 MSI has been mainly associated with cancer 14 or cancer risk. 11 An interesting finding of our study was that five of the six secondary malignancies reported in our patient cohort were observed in patients of the MSI þ group. Moreover, the median time of clinical follow-up of MSI þ patients was half the median follow-up of the MSI À patients. As the risk for the development of secondary malignancy increases over time, we would expect that the MSI þ patients would have lower incidence of secondary cancer. 5 By applying time-dependent statistical analysis we found a significant association between secondary malignancy and MSI status. This observation might implicate GI with secondary cancer development. Of course the small number of secondary malignancies does not allow us to make statistically safe correlations or to suggest MSI as a possible predictive biomarker. Further evaluation in prospective studies is needed. It is very likely that mutations occur not only in nontranscribed microsatellites but also in coding regions of the genome. Socie and co-workers found in eight post-transplant tumors a p53 expression indicative for mutations of the p53 gene. 5 In line with that, we found p53 mutations in two of four post-transplant tumors. In addition, we sequenced exons 5-8 of the p53 gene in six MSI þ samples but we did not find any mutations (Supplementary Table 2 ).
The results of this study confirm that GI of epithelial cells is a frequent phenomenon in patients after allo-HCT and provide novel in vivo and in vitro support that alloantigeneic processes can be the cause of such a phenomenon. Our observation that older donor age and female-to-male transplantations favor the occurrence of MSI may have implications in donor selection, however further research is required. In addition, our in vitro data suggest that ROS generated during alloreactions are implicated in the induction of GI and this may be inhibited through antioxidants. Focusing on the pathways through which alloantigeneic reactions cause GI may bring up novel therapeutic targets for the protection of the epithelium during GvHD and the prevention of malignant transformation.
